News
CHICAGO -- Champions of tricuspid transcatheter edge-to-edge repair (TEER) were buoyed by 2-year results of the TRILUMINATE trial marking the first report of reduced heart failure (HF ...
In February, the FDA’s Circulatory System Devices Panel voted to recommend the transcatheter edge-to-edge repair (TEER) device (TriClip) for patients with severe tricuspid regurgitation ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback